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Although there is a growing body of data on the mo lecular actions of benzodiazepines (BZs) with the BZ/ gamm a aminobutyric acid-a receptor complex, the neu roanatomic site(s) at which these compounds act to en hance sleep are poorly understood. In a series of studies in which the BZ hypnotic triazolam was microinjected into nuclei thought to be associated with sleep regula tion, we have previously observed that administration into the medial preoptic area (MP A) during the day time enhances sleep, and no effect occurs after injec tioninto two nearby structures; this effect is prevented by the BZ receptor blocker RO 15-1788 (Mendelson and Martin 1992) . To further characterize this action of tria mlam, we are exploring the possibility that the drug induced sleep enhancement may be mediated by alter iilns in cellular calcium channel activity. This approach derives from observations that increased 45CA + + up-found that nifedipine alone had no significant effects on sleep and prevented sleep induction by triazolam. There were no drug-specific effects on core temperature in any treatment condition. These data suggest that dihydro pyridine-sensitive sites may be involved in the mechanism of sleep induction by BZs. [Neuropsychopharmacology 8:227-232, 1993J take into synaptosomes induced by low concentrations (1 J.1m) of diazepam is prevented by the dihydropyri dine calcium channel blocker, nifedipine (Mendelson at al. 1984a) , and that in vivo intraventricular adminis tration of nifedipine prevents sleep induction by sys temically administered fiurazepam (Mendelson et al. 1984b) . Conversely, sleep induction by parenteral fiur azepam is potentiated by Bay K 8644, a dihydropyridine that increases uptake of 45CA + + into synaptosomes (Mendelson 1987) . In the present study, we observed sleep and core temperature following coinjection of tria zolam and nifedipine into the MP A of rats.
METHODS
This study had a modifIed Latin-square design in which all animals were given triazolam 0.25 and 0.5 J.1g (0.73 nmol and 1.46 nmol) and its vehicle, in combination with nifedipine 16 J.1g (46 nmol) and its vehicle. Each animal received all six treatment combinations. All treat ments and recordings were separated by 1 week. The study was performed on 15 male Sprague-Dawley al bino rats weighing between 250 and 300 g, purchased from Taconic Farms (Germantown, NY). After the sur gical implantation of cannulae and electrodes (Mendel son and Martin 1992) , the rats were housed individu ally in smooth-walled plastic cages for at least 1 week 0893-133X/93/$6.oo prior to use in a study. Lights were on from 8:00 A.M. until 8:00 P.M. The ambient temperature was main tained with at 26.25 ± 0.06°C; an analysis of variance (ANOV A) revealed no signmcant differences between ambient temperature across the treatment conditions.
Techniques for anesthesia and surgical implanta tion of cannulae have been described in detail in previ ous publications (Mendelson and Martin 1992) . In sum mary, rats were placed in a Kopf stereotaxic apparatus with a mouth bar adjusted to provide a horizontal plane for the lambda and bregma. After a scalp incision was made and the skull exposed, holes were drilled at stereotactically determined locations. The dura was then gently disrupted at the holes and bilateral 24-gauge stainless-steel guide cannulae were lowered to 1 mm above the brain site of interest. The stereotaxic coor dinates of the tip of the guide cannula (in mm), derived originally from Paxinos and Watson (1986) , and as sessed from previous work, and pilot studies were as follows AP: -0.4; ML: +0.5; DV: -7.l.
During the same surgical procedure, four 0-80 stainless-steel screws were implanted through the skull to serve as dural electroencephalographic (EEG) elec trodes. These screws were connected to an Amphenol socket by short lengths of O.OlO-in. Teflon-coated, stainless-steel wire. The stripped ends of two other lengths of this wire were implanted in the neck mus culature to act as electromyographic (EMG) electrodes and these were also connected to the Amphenol socket. Before releasing the rat from the stereotaxic apparatus, the entire assembly of cannulae, electrodes, and Am phenol socket was cemented in place with dental acrylic. The edges of the wound were then treated with an ointment containing bacitracin, polymyxin, and neo mycin. Finally, the guide cannulae were occluded with 31-gauge stainless-steel stylets of matching length, and a protective plug was placed in the Amphenol socket.
To adapt the animals to the recording environment, they were placed in the recording chambers at 4:00 P. M. on the day before the experiment. At 10:00 A.M. the next morning, the stylet was removed from each guide can nula, and an injection cannula of 31-gauge stainless steel tubing was inserted so that the tip extended pre cisely 1 mm past the tip of the guide cannula into the brain. Triazolam (kindly supplied by the Vpjohn Co., Kalamazoo, MI) or nifedipine (kindly supplied by Miles Pharmaceuticals, West Haven, CT), or vehicle was fIrst warmed to 37°C, and then injected from a 10-111 Hamil ton syringe through a length of PE 20 tubing attached to the injection cannula. The injection for each drug was given in a volume of 0.2111 of each side, administered over 1 minute, using a syringe pump, and the inner cannula was then left in place for 30 seconds. The volumes and infusion rate were derived from the work of Myers (1966) , to minimize tissue damage and restrict diffusion of drug from the injection site. One syringe NEUROPSYCHOPHARMACOLOGY 1993-VOL. 8, NO.1 was used for each side, and injections were essentially simultaneous. Triazolam was dissolved in a 1:1 mix· ture of Emulphor polyoxyethylated vegetable oil and ethanol. Just prior to the injection, the solution was diluted 10-fold with artmcial cerebrospinal fluid (Meft.
delson and Martin 1992). All drug vehicles were fIISI passed through a Millipore Millex-HV 0.45-l1m biter. The total doses of triazolam for both sides combined were 0.25 Ilg (0.73 nmol) and 0.5 Ilg (1.46 nmol). Nifei pine was prepared by dissolving 40 mg (115 I1mol) I 300 III of a 1: 1 mixture of polyethylene glycol and. nol, and diluting with 700 III of distilled water. Bilatem injections of 0.2 ilIon each side were administered II described above, for a total dose of 161lg (46 nmol). fd. lowing the injection, the stylet was replaced and the study begun.
Following the injection of drug, each rat was placed back in its testing chamber and a cable to a Grass Modi! 78 polygraph was attached to the Amphenol connec· tor on the rat's headset. Three traces representiJ1 bifrontal EEG, frontooccipital EEG, and EMG Weft recorded for 2 hours for each rat. The paper speed WII 10 mm/sec and the vertical deflection of the pen was calibrated so that 1 em signmed an electrical poten&! of 50 IlV. After the recording, animals were returned to their housing and subsequent tests of further drus treatment conditions were performed at weekly in tervals.
At the end of the study, a single investigator (who was unaware of the treatment condition) classifJ.edeadl 30-second epoch as "waking," "nonrapid-eye mow ment (nonREM) sleep," or "REM sleep" (Mendelsonet al. 1974) . The results were then tallied and reportedia terms of parameters including total sleep time, sl eep latency (time from drug injection until the frrst time consecutive 30-second epochs of sleep), intermitlelt waking time (waking time after initial sleep onset), RB( latency (time from sleep onset until the frr st two em secutive epochs of REM sleep), nonREM sleep time, and REM sleep time (Mendelson et al. 1978) . As ourprevi ous study (Mendelson and Martin 1992) indicatedtIB drug-induced changes in sleep were largely confined to the fIrst 2 hours after administration, we presentda for this period only.
After a rat underwent all the weekly drug tr& ments and EEG recordings for a given experimentalprt tocol, an injection of 400 mg/kg (1.61 rnmollkg) olio dium pentobarbital was given intraperitoneall y andlbe animal was perfused transcardially as described previ ously (Mendelson and Martin 1992) . The rat wasths decapitated and the brain removed and stored in the formalin solution. Coronal brain sections (4811M)wm cut on a freezing microtome, mounted on slides, and stained with cresyl violet. The tip of the injectioncan nula track was then localized by light microscopy. FIt ure 1 demonstrates the injection sites in all animals. 
Measurement of Core Body Temperature
Core temperature was assessed by means of the MiniMitter system, which includes a transmitter im planted intraperitoneally at the time of the surgical placement of the EEG electrodes. This transmitter sends out a signal that encodes temperature. A receiver is situ ated underneath each of the testing cages and the sig nal is decoded by an IBM PC microcomputer.
For eac h animal, temperature was recorded for a !}.minute baseline period before drug injection, and for 6 hours after injection. Measures of temperature in duded mean temperature for the 1st and 2nd hours af ter drug injection, difference in temperature between Triazolam Injections into the MP A 229 Treatment Effect (ANOVA): * df 5, 70, F = 7.499949, P < 0.00001; ** df 5, 70, F = 3.323156, P < 0.01; *** df 5, 70, F = 3.973966, P < 0.003; **** df 5, 20, F = 2.927064, P < 0.04. baseline and the mean of the 1st and 2nd hours, tem perature at sleep onset, maximum temperature over the 6-hour period, and time from drug injection until max imum temperature.
Statistical Analysis
Data were assessed by one-way ANOV A, using a within groups design for one factor (treatment) with six levels. In those cases in which there were signiftcant 
Figure 2. Typical core tem perature curves of a rat receiv ing all six treatments. There was no significant drug effect on temperature (Table 2) , and all groups had a similar tran sient increase in core tempera ture. It should be noted that the computer program that gener ates these curves uses auto matic scaling, such that the scaling diff ers slightly in the diff erent conditions. Abbrevi ations: V = vehicle; D = active drug; Nifed. = nifedipine; and T = triazolam. (Mendelson et al. 1986 ). Thus, when we ob terVed a decrease in sleep latency and an increase in 
